Whitehawk Therapeutics (WHWK) Invested Capital (2020 - 2021)
Whitehawk Therapeutics' (WHWK) quarterly Invested Capital came in at $258000.0 in Q4 2021, down 98.2% year-on-year from $14.3 million in Q4 2020, and up 1072.73% on a QoQ basis from $22000.0 in Q3 2021.
Whitehawk Therapeutics (WHWK) Invested Capital (2020 - 2021) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 2 years of Invested Capital data on file, last reported at $258000.0 in Q4 2021.
- On a quarterly basis, Invested Capital fell 98.2% year-over-year to $258000.0 in Q4 2021; TTM through Sep 2022 was $258000.0, a 98.2% decrease from a year earlier, with the FY2021 full-year figure at $258000.0, down 98.2% from the prior year.
- Invested Capital for Q4 2021 stood at $258000.0, up from $22000.0 in the prior quarter.
- Over the last five years, Invested Capital for WHWK reached as high as $14.3 million in Q4 2020 and fell as low as $22000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 258,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Dec 31, 2020 | 14.31 Mn |